ARCHIVES

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Hawkins Gets Seat Back On Labor & Human Resources, Loses Subcommittee; Foundation Offers Fellowships

February 11, 1983

Clinical Trials: Stories On Results Can Have Unintended Consequences

May 15, 1998

CTEP Deploys Website To Track Trial Activation

December 10, 2010

Michigan’s Zhang Wins “Protein Science Olympics”

January 14, 2011

Avoiding Mediastinal Radiation Can Improve Patient Outcomes

April 26, 2013

NCI to Establish Three Grants Programs Supporting Clinical Cancer Research

February 18, 1994